Acadia Pharmaceuticals ACAD
NASDAQ ACAD
$20.19 -0.25 (-1.22%)
At close: Oct 21, 2026 · 4:00 PM EDT

Acadia Pharmaceuticals (ACAD) Gross Profit (2016 - 2026)

Updated

Acadia Pharmaceuticals (ACAD) recorded Gross Profit of $279.64 million in Q2 2026, up 14.7% from $243.83 million a year earlier and up 15.0% from the prior quarter.

Analysis

Acadia Pharmaceuticals (ACAD) Gross Profit (2016 - 2026) Analysis & Trends

On a TTM basis, Acadia Pharmaceuticals' Gross Profit came in at $1.04 billion as of Jun 30, 2026, up 10.7% year-over-year; for FY2025, it came in at $982.51 million, up 12.2% from FY2024.

  • Annual Gross Profit has increased for nine straight years, with a five-year compound annual growth rate of 17.9% (FY2020 to FY2025).
  • Across earlier years, Gross Profit came in at $875.96 million in FY2024 (+27.9%), $684.8 million in FY2023 (+35.1%), $507.07 million in FY2022 (+9.0%) and $465 million in FY2021 (+7.8%).
  • The Q2 2026 figure is the highest quarterly Gross Profit in data going back to Q2 2016.
  • On a year-over-year basis, Gross Profit has increased for 36 consecutive quarters, with growth averaging 12.9% over the last eight quarters.
  • The year-over-year growth in Gross Profit has ranged between 0.5% (Q3 2022) and 59.0% (Q4 2023) over the last five years.
  • Per Business Quant, the preceding three quarters came in at $243.27 million (Q1 2026), $257.76 million (Q4 2025) and $256.99 million (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
API Access

Acadia Pharmaceuticals Gross Profit API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-profit&ticker=ACAD&period=max&api_key=YOUR_API_KEY